Skip to main content

Table 1 One-year prevalence (per 1000 inhabitants < 18 years of age) of psychotropic drug use among 0–17 year olds a; overall and in psychotropic drug subcategories, in the period 2004-2014

From: Psychotropic drug use among 0–17 year olds during 2004–2014: a nationwide prescription database study

Boys 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
 N= 555,198 557,821 560,169 561,730 563,373 565,599 568,891 571,362 573,463 575,654 576,584
 Alimemazine (R06DA01) 8.3 7.1 7.0 7.0 5.8 5.7 6.3 5.6 4.9 4.4 4.5
 Hypnotics/sedatives (N05C) 4.2 5.3 6.1 7.3 7.9 8.7 9.5 10.0 10.1 10.1 10.8
 Stimulants (N06BA) 15.0 16.9 17.5 18.7 19.7 20.5 21.0 20.8 20.7 20.6 20.8
 Antidepressants (N06A) 2.1 1.7 1.7 1.8 1.8 2.0 2.2 2.2 2.2 2.1 2.0
 Antipsychotics (N05A) 1.6 1.8 1.9 2.0 2.2 2.3 2.3 2.4 2.3 2.2 2.2
 Anxiolytics (N05B) 4.7 4.8 4.9 4.9 4.5 4.6 4.6 4.7 4.6 4.2 3.9
 Total psychotropics 30.6 30.7 31.8 33.5 33.5 35.0 37.0 36.7 35.9 34.7 35.3
Girls 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
 N= 527,128 530,212 532,559 534,273 535,906 537,882 540,265 543,012 544,762 547,243 548,577
 Alimemazine (R06DA01) 7.1 6.4 6.4 6.4 5.3 4.9 5.5 5.5 5.1 4.6 4.7
 Hypnotics/sedatives (N05C) 2.6 3.2 3.7 4.4 5.1 5.7 6.4 7.0 7.7 8.0 8.8
 Stimulants (N06BA) 3.8 4.9 5.5 6.3 7.0 7.4 7.9 7.9 8.1 8.3 8.5
 Antidepressants (N06A) 3.1 2.5 2.4 2.6 2.6 2.6 2.8 3.0 3.6 4.0 10.0
 Antipsychotics (N05A) 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.2 1.5 1.5 1.6
 Anxiolytics (N05B) 4.5 4.7 4.7 4.7 4.4 4.4 4.2 4.4 4.5 4.1 3.9
... Total psychotropics 19.2 19.0 19.7 20.9 20.7 21.1 22.9 23.6 24.5 24.2 25.0
  1. aage composition of the overall Norwegian population aged 0–17 years did not change significantly in the period 2004–2014